Mentice AB (publ) (STO:MNTC)

Market Cap	386.73M +10.0%
Revenue (ttm)	303.13M +15.9%
Net Income	-4.61M
EPS	-0.16
Shares Out	28.13M
PE Ratio	n/a
Forward PE	293.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,698
Open	13.55
Previous Close	13.55
Day's Range	13.55 - 13.80
52-Week Range	8.50 - 18.00
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as t...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 109
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2025, Mentice AB's revenue was 279.09 million, a decrease of -3.87% compared to the previous year's 290.33 million. Losses were -32.33 million, 75.5% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error